Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Immune Design's peak revenue was $13.3M in 2016. The peak quarterly revenue was $8.2M in 2016(q3).
Immune Design's revenue increased from $1.6m in 2013 to $2.2M currently. That's a 37.34% change in annual revenue.
| Fiscal year / year | Immune Design revenue |
|---|---|
| 2013 | $1.6M |
| 2014 | $6.4M |
| 2015 | $9.5M |
| 2016 | $13.3M |
| 2017 | $7.2M |
| 2018 | $2.2M |
How accurately did Immune Design's revenue projections match actual performance?
Immune Design saw the greatest revenue growth in 2014, when revenue increased by 302.31%.
Immune Design had the lowest revenue growth in 2018, when revenue changed by -69.48%.
| Year | Immune Design growth |
|---|---|
| 2014 | 302%↑ |
| 2015 | 48%↑ |
| 2016 | 39%↑ |
| 2017 | -46%↓ |
| 2018 | -69%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | $1.1M | $3.5M | $1.8M |
| 2015 | $1.9M | $1.8M | $4.7M | $1.1M |
| 2016 | $1.9M | $1.1M | $8.2M | $2.1M |
| 2017 | $5.5M | $729,000 | $516,000 | $485,000 |
| 2018 | $503,000 | $755,000 | $462,000 | $476,000 |
Do you work at Immune Design?
Did Immune Design meet its revenue projections?
| CEO | Carlos Paya |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 48 |
| Date Founded | 2008 |
| Headquarters | Seattle, Washington |
| Number of Locations | 1 |
| Revenue | $2.2M |
| Net Income | -$54,758,000 |
| Gross Proft | $761,000 (2018) |
| PE Ratio | -2.15 |
| Market Capitalization | $117.9M |
| Total Assets | $100,960,000 |
| Ticker | IMDZ |
Immune Design received early financing of $18.0M on 2008-07-07.
| Series | Round size | Date |
|---|---|---|
| Series A | $18M | 07/2008 |
| Series B | $32M | 07/2010 |
| Series C | $49M | 10/2013 |
| Post Ipo Equity | $79.5M | 04/2015 |
| Investors | Security type |
|---|---|
| Osage University Partners | Series A |
| Versant Ventures | Series A |
| Alta Partners | Series A |
| The Column Group | Series A |
| ProQuest Investments | Series B |
| Osage University Partners | Series B |
| Versant Ventures | Series B |
| Alta Partners | Series B |
| The Column Group | Series B |
| Topspin Partners | Series C |
| ProQuest Investments | Series C |
| Osage University Partners | Series C |
| Versant Ventures | Series C |
| Alta Partners | Series C |
| Sanofi Ventures | Series C |
| The Column Group | Series C |
Zippia gives an in-depth look into the details of Immune Design, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Immune Design. The employee data is based on information from people who have self-reported their past or current employments at Immune Design. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Immune Design. The data presented on this page does not represent the view of Immune Design and its employees or that of Zippia.
Immune Design may also be known as or be related to IMMUNE DESIGN CORP., Immune Design, Immune Design Corp and Immune Design Corp.